Gilead agrees 127-country remdesivir licence with generic makers

14-05-2020

Rory O'Neill

Gilead agrees 127-country remdesivir licence with generic makers

Sundry Photography / Shutterstock.com

Gilead has agreed to license its antiviral remdesivir to five generic makers for distribution during the COVID-19 pandemic.


Gilead, remdesivir, COVID-19, pandemic, WHO, Japan, antiviral, pharmaceuticals, drug, FDA, clinical trial, vaccine, Mylan, Cipla, Ferozsons, Hetero

LSIPR